Skip to content
Back to search results

Questionnaire on Smoking Urges—Brief (QSU-Brief)

Introduced by
Cox, Tiffany, Christen
Year
1996
Type
Self-report
Family
craving-assessment
Font size

What does it do?

The QSU-Brief is a 10-item self-report instrument that rapidly assesses the intensity of craving for cigarettes and the intention to smoke.

Developed by Cox, Tiffany, and Christen in 1996, it is a brief version of the longer Questionnaire on Smoking Urges (QSU) and is widely used in smoking cessation treatment and research settings to measure one of the strongest predictors of smoking relapse. The QSU-Brief is also applicable, with adaptation, to other addictive substances.

The intuition behind the method

The QSU-Brief operationalizes craving as a multidimensional construct encompassing both the desire or urge to smoke and the intention or anticipation of smoking. Rather than measuring consumption quantity, it captures the subjective experience of wanting to smoke, which is one of the strongest proximal predictors of smoking lapse and relapse. The instrument recognizes that craving fluctuates across situations and time, and that tracking craving during treatment provides real-time data on treatment response and relapse risk.

History

The QSU-Brief was developed by Cox, Tiffany, and Christen at the University of Connecticut and published in Nicotine & Tobacco Research in 1996. The brief version was created as a practical alternative to the longer 32-item QSU to reduce respondent burden while maintaining strong validity for predicting smoking relapse. The QSU-Brief has been extensively validated in smoking cessation clinical trials and is adopted as a standard outcome measure in many cessation treatment programs. It has also been adapted with minor wording changes for use with other addictive substances (cannabis, opioids, alcohol).

When to use it

The QSU-Brief is appropriate for use during smoking cessation treatment to monitor craving intensity, predict short-term relapse risk, and guide therapeutic adjustments. It is useful at multiple time points (e.g., daily or weekly during the critical early quit period, or during high-risk situations). The QSU-Brief is less suitable as a pre-treatment screening tool; use it only in individuals who have already decided to quit smoking or are engaged in cessation treatment.

Limitations and considerations

  • Measures craving only; does not assess other important relapse predictors (e.g., mood, social support, coping skills)
  • Craving is necessary but not sufficient for relapse; some individuals experience high craving without lapsing
  • Depends on self-report and may be subject to random response variability or measurement error
  • Short-term predictive validity (24–48 hours); longer-term prediction requires integration with other factors

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Brief, validated instrument requiring minimal time to administer while capturing a strong predictor of smoking relapse
  • Continuous score provides fine-grained assessment of craving fluctuations across treatment
  • Highly predictive of imminent smoking lapse (within 24–48 hours), enabling timely intervention
  • Responsive to treatment effects; scores decline during successful cessation treatment
  • Applicable across smoking contexts and populations, with translations available in multiple languages

Applications

  • Daily or weekly monitoring of craving intensity during smoking cessation treatment to predict imminent relapse risk and guide therapeutic adjustments
  • Assessment of high-risk situations (e.g., post-meal, during stress) to tailor coping strategy training and environmental management
  • Evaluation of pharmacological treatments (nicotine replacement, varenicline, bupropion) by tracking craving reduction over time
  • Research studies investigating temporal associations between craving and smoking lapse, and predictors of successful cessation
  • Telehealth and remote cessation programs where brief, frequently administered measures improve monitoring and engagement

How it works

How it works

1

The QSU-Brief comprises 10 items asking directly about the strength of urge to smoke ('I have a desire to smoke right now') and intention or expectation ('I would smoke if I were in a situation where I have just finished eating a meal'). Items may be administered on visual analog scales (VAS; 0–100 mm) or on Likert-type scales (0–4, from Strongly disagree to Strongly agree). The measure is self-administered and takes approximately 2–3 minutes to complete. It can be administered in person, by telephone, or electronically.

Formula
10 items (brief version) rated on a 100-mm visual analog scale or 0–4 Likert scale assessing strength and intention to smoke
2

All 10 items are summed to yield a total craving score. On Likert-type scales, the total ranges from 0 to 40 (higher = greater craving). On VAS, scores range from 0 to 1000 (aggregated from individual 100-mm scales). No subscales or reverse scoring are used in standard scoring. Scores are directly interpretable: higher values indicate greater intensity of craving and intention to smoke.

Formula
Sum all item responses. Total range 0–40 (Likert version) or 0–1000 (VAS version). Higher scores indicate greater craving intensity.
3

The QSU-Brief score is a continuous measure of craving intensity with higher scores indicating greater likelihood of smoking in the near term. Scores above 30 (on the 0–40 Likert scale) indicate substantial craving intensity and heightened relapse risk. Craving scores fluctuate across treatment; declining scores generally reflect treatment progress and strengthening of abstinence, while increasing scores may precede relapse and warrant intervention intensification. The QSU-Brief is highly predictive of smoking lapse within 24–48 hours of assessment.

Formula
Higher scores predict greater relapse risk and smoking lapse probability in the near term. Scores ≥30 on Likert scale indicate significant craving intensity.

Common pitfalls

  • Interpreting high craving as inevitable relapse; high craving can be managed with coping skills and social support
  • Failing to respond to rising craving with therapeutic intervention (e.g., coping strategies, medication adjustment)
  • Comparing QSU-Brief scores across different response format scales (VAS vs. Likert) without converting to common metric
  • Neglecting to assess triggers and context for craving increases; situational assessment complements craving scores

Frequently asked questions

What craving score should trigger action?

Scores above 30 on the 0–40 Likert scale indicate significant craving and warrant therapeutic response. However, any upward trajectory or rising craving despite treatment may warrant intervention. Work with your clinician to develop coping strategies for managing high-craving situations.

Can high QSU-Brief scores predict whether I will relapse?

QSU-Brief scores are strong predictors of smoking lapse within 24–48 hours, but high craving does not guarantee relapse. Many individuals experience high craving and successfully manage it through coping skills and support. The score indicates risk, not certainty.

How often should I complete the QSU-Brief?

Frequency depends on treatment intensity. During the critical early quit period (first 2–4 weeks), daily or multiple-times-daily assessment provides valuable data. As abstinence stabilizes, weekly or monthly assessment may suffice. Use high-risk periods (stress, social situations) as triggers for assessment.

Can QSU-Brief be used for other drugs besides cigarettes?

Yes, the QSU-Brief has been adapted with minor wording changes ('desire to use [drug]' instead of 'smoke') to assess craving for cannabis, opioids, alcohol, and other substances. The underlying construct (urge intensity and intention) applies broadly across addictive substances.

What if my QSU-Brief scores are low but I'm still smoking?

Low craving does not guarantee abstinence. Smoking may be maintained by habit, context cues, or other factors beyond subjective craving. Conversely, environmental or cognitive cues may trigger smoking despite low reported craving. Work with your clinician to identify triggers and develop comprehensive cessation strategies beyond craving management.

Is there a difference between QSU-Brief and the longer QSU?

The QSU-Brief (10 items) is a shortened version of the full QSU (32 items). Both measure craving, but the brief version is more practical for frequent administration. Psychometric properties are comparable; use QSU-Brief in most clinical settings unless comprehensive measurement is specifically needed.

Related methods

Sources

  1. Cox, L. S., Tiffany, S. T., & Christen, A. G. (1996). Evaluation of the brief Questionnaire of Smoking Urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 2(1), 7–16.

    Open publication reference
    Copied.